Details of the Drug
General Information of Drug (ID: DMW9F89)
| Drug Name |
Labetuzumab govitecan
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | UNII-8E3HI6QQ9J; hMN14-SN38; Labetuzumab govitecan [USAN]; IMMU 130; 8E3HI6QQ9J; DB12331; 1469876-18-3 | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||

